Systemic complications of acromegaly and the impact of the current treatment landscape: an update

MR Gadelha, L Kasuki, DST Lim… - Endocrine reviews, 2019 - academic.oup.com
Acromegaly is a chronic systemic disease with many complications and is associated with
increased mortality when not adequately treated. Substantial advances in acromegaly …

Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)

SR Cairns, JH Scholefield, RJ Steele, MG Dunlop… - Gut, 2010 - gut.bmj.com
The British Society of Gastroenterology (BSG) and the Association of Coloproctology for
Great Britain and Ireland (ACPGBI) commissioned this update of the 2002 guidance. The …

Acromegaly: an endocrine society clinical practice guideline

L Katznelson, ER Laws Jr, S Melmed… - The Journal of …, 2014 - academic.oup.com
Objective: The aim was to formulate clinical practice guidelines for acromegaly. Participants:
The Task Force included a chair selected by the Endocrine Society Clinical Guidelines …

[HTML][HTML] American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update

L Katznelson, JLD Atkinson, DM Cook… - Endocrine …, 2011 - endocrinepractice.org
AACE= American Association of Clinical Endocrinologists; BEL=“best evidence” level;
BMD= bone mineral density; CPAP= continuous positive airway pressure; CPG= clinical …

Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature

J Dal, MZ Leisner, K Hermansen… - The Journal of …, 2018 - academic.oup.com
Context Acromegaly has been associated with increased risk of cancer morbidity and
mortality, but research findings remain conflicting and population-based data are scarce. We …

Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database

B Gatta-Cherifi, O Chabre, A Murat… - European journal of …, 2012 - academic.oup.com
Objective Limited data regarding adrenal involvement in multiple endocrine neoplasia type
1 (MEN1) is available. We describe the characteristics of MEN1-associated adrenal lesions …

[HTML][HTML] 60 years of neuroendocrinology: acromegaly

C Capatina, JAH Wass - Journal of Endocrinology, 2015 - joe.bioscientifica.com
Acromegaly (ACM) is a chronic, progressive disorder caused by the persistent
hypersecretion of GH, in the vast majority of cases secreted by a pituitary adenoma. The …

[HTML][HTML] Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis

T Rokkas, D Pistiolas, P Sechopoulos… - World journal of …, 2008 - ncbi.nlm.nih.gov
AIM: To examine the risk of colorectal neoplasm in acromegalic patients by meta-analyzing
all relevant controlled studies. METHODS: Extensive English language medical literature …

Risk of neoplasia in pediatric patients receiving growth hormone therapy—a report from the Pediatric Endocrine Society Drug and Therapeutics Committee

S Raman, A Grimberg, SG Waguespack… - The Journal of …, 2015 - academic.oup.com
Context: GH and IGF-1 have been shown to affect tumor growth in vitro and in some animal
models. This report summarizes the available evidence on whether GH therapy in childhood …

[HTML][HTML] Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly–meta-analysis and systematic review

K Wolinski, A Czarnywojtek, M Ruchala - PLoS One, 2014 - journals.plos.org
Introduction Acromegaly is a quite rare chronic disease caused by the increased secretion of
growth hormone (GH) and subsequently insulin-like growth factor 1. Although …